{"entity":{"type":"insider","cik":"0001789076","url":"/insider/0001789076","json_url":"/insider/0001789076.json","name":"Attar Eyal C.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":7,"first":"2019-10-07","last":"2025-02-18","span_basis":"filed_date"},"name_variants":[{"name":"Attar Eyal C.","source":"filing","n_filings":7,"first_seen":"2019-10-07","last_seen":"2025-02-18"}],"transactions":[{"id":4280676,"accession":"0001415889-25-004406","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-004406","line_url":"/filing/0001415889-25-004406#line-1","is_derivative":false,"issuer_cik":"0001789076","issuer_name":"Vor Biopharma Inc.","issuer_ticker":"VOR","issuer_name_source":null,"issuer_url":"/issuer/0001789076","owner_cik":"0001789076","owner_name":"Attar Eyal C.","owner_display_name":"Attar Eyal C.","owner_url":"/insider/0001789076","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2227.0,"shares_display":"2,227","price_per_share":1.42,"price_display":"1.42","price_state":"stated","total_value":3162.34,"total_display":"3,162.34","total_whole":"3,162","shares_owned_after":126625.0,"shares_owned_after_display":"126,625","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-13","filed_date":"2025-02-18","scope":"insider"},{"id":4107938,"accession":"0001415889-25-003734","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-003734","line_url":"/filing/0001415889-25-003734#line-1","is_derivative":false,"issuer_cik":"0001789076","issuer_name":"Vor Biopharma Inc.","issuer_ticker":"VOR","issuer_name_source":null,"issuer_url":"/issuer/0001789076","owner_cik":"0001789076","owner_name":"Attar Eyal C.","owner_display_name":"Attar Eyal C.","owner_url":"/insider/0001789076","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2554.0,"shares_display":"2,554","price_per_share":1.37,"price_display":"1.37","price_state":"stated","total_value":3498.98,"total_display":"3,498.98","total_whole":"3,499","shares_owned_after":128852.0,"shares_owned_after_display":"128,852","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-10","filed_date":"2025-02-12","scope":"insider"},{"id":2712736,"accession":"0001415889-24-030316","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-030316","line_url":"/filing/0001415889-24-030316#line-1","is_derivative":false,"issuer_cik":"0001789076","issuer_name":"Vor Biopharma Inc.","issuer_ticker":"VOR","issuer_name_source":null,"issuer_url":"/issuer/0001789076","owner_cik":"0001789076","owner_name":"Attar Eyal C.","owner_display_name":"Attar Eyal C.","owner_url":"/insider/0001789076","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10334.0,"shares_display":"10,334","price_per_share":1.25,"price_display":"1.25","price_state":"stated","total_value":12917.5,"total_display":"12,917.50","total_whole":"12,918","shares_owned_after":81439.0,"shares_owned_after_display":"81,439","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-27","filed_date":"2024-12-31","scope":"insider"},{"id":2661021,"accession":"0001415889-24-015450","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-015450","line_url":"/filing/0001415889-24-015450#line-1","is_derivative":false,"issuer_cik":"0001789076","issuer_name":"Vor Biopharma Inc.","issuer_ticker":"VOR","issuer_name_source":null,"issuer_url":"/issuer/0001789076","owner_cik":"0001789076","owner_name":"Attar Eyal C.","owner_display_name":"Attar Eyal C.","owner_url":"/insider/0001789076","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14645.0,"shares_display":"14,645","price_per_share":1.39,"price_display":"1.39","price_state":"stated","total_value":20356.55,"total_display":"20,356.55","total_whole":"20,357","shares_owned_after":96063.0,"shares_owned_after_display":"96,063","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-03","filed_date":"2024-06-04","scope":"insider"},{"id":6536795,"accession":"0001104659-22-028757","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-028757","line_url":"/filing/0001104659-22-028757#line-1","is_derivative":false,"issuer_cik":"0001781983","issuer_name":"Aprea Therapeutics, Inc.","issuer_ticker":"APRE","issuer_name_source":null,"issuer_url":"/issuer/0001781983","owner_cik":"0001789076","owner_name":"Attar Eyal C.","owner_display_name":"Attar Eyal C.","owner_url":"/insider/0001789076","role":"Officer (SVP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36000.0,"shares_display":"36,000","price_per_share":1.73,"price_display":"1.73","price_state":"stated","total_value":62280.0,"total_display":"62,280.00","total_whole":"62,280","shares_owned_after":47000.0,"shares_owned_after_display":"47,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-28","filed_date":"2022-03-01","scope":"insider"},{"id":4312555,"accession":"0001104659-21-117446","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-117446","line_url":"/filing/0001104659-21-117446#line-1","is_derivative":false,"issuer_cik":"0001781983","issuer_name":"Aprea Therapeutics, Inc.","issuer_ticker":"APRE","issuer_name_source":null,"issuer_url":"/issuer/0001781983","owner_cik":"0001789076","owner_name":"Attar Eyal C.","owner_display_name":"Attar Eyal C.","owner_url":"/insider/0001789076","role":"Officer (SVP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15968.0,"shares_display":"15,968","price_per_share":4.68,"price_display":"4.68","price_state":"stated","total_value":74730.24,"total_display":"74,730.24","total_whole":"74,730","shares_owned_after":83000.0,"shares_owned_after_display":"83,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-16","filed_date":"2021-09-20","scope":"insider"},{"id":8059973,"accession":"0001140361-19-018074","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-19-018074","line_url":"/filing/0001140361-19-018074","is_derivative":false,"issuer_cik":"0001781983","issuer_name":"Aprea Therapeutics, Inc.","issuer_ticker":"APRE","issuer_name_source":null,"issuer_url":"/issuer/0001781983","owner_cik":"0001789076","owner_name":"Attar Eyal C.","owner_display_name":"Attar Eyal C.","owner_url":"/insider/0001789076","role":"Officer (SVP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":6000.0,"total_display":"6,000.00","total_whole":"6,000","shares_owned_after":200.0,"shares_owned_after_display":"200","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-10-07","filed_date":"2019-10-07","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001817229","name":"Vor Biopharma Inc.","url":"/issuer/0001817229","role":"Officer (CHIEF MEDICAL OFFICER)","n_filings":4,"first_seen":"2024-06-04","last_seen":"2025-02-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001781983","name":"Aprea Therapeutics, Inc.","url":"/issuer/0001781983","role":"Officer (SVP, Chief Medical Officer)","n_filings":3,"first_seen":"2019-10-07","last_seen":"2022-03-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001789076","retrieved_at":"2026-08-23T21:49:54+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}